A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections

BACKGROUND: Over many years, OM-85, a lysate of 21 common bacterial respiratory pathogens, has been demonstrated to prevent respiratory recurrences in children. However, further studies are needed to explore the true importance of OM-85 in the prevention of respiratory tract infections (RTIs) in chi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Transl Med
Glavni autori: Esposito, Susanna, Bianchini, Sonia, Bosis, Samantha, Tagliabue, Claudia, Coro, Ilaria, Argentiero, Alberto, Principi, Nicola
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6708164/
https://ncbi.nlm.nih.gov/pubmed/31443716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2040-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items